Received Jul 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | E4A39 | — |
administered an expired dose of Menveo; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 19-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number E4A39, expiry date 30-JUN-2025) for prophylaxis. On 15-JUL-2025, the patient received Menveo. On 15-JUL-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: administered an expired dose of Menveo). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 15-JUL-2025 The registered Nurse called but there were connectivity issues and outbound call was placed and caller explained she administered an expired dose of Menveo (1-vial) to a patient on 15-JUL-2025. Dose expired on J30-JUN-2025, which led to expired vaccine used.